{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T20:14:59Z","timestamp":1784837699609,"version":"3.55.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Hydroxyethyl starch (HES) is commonly used as plasma expander during surgery but may be nephrotoxic as seen in studies in patients with sepsis. The authors hypothesized that the possible nephrotoxicity of 6% HES 130\/0.4 could be revealed by measurements of urinary excretion of neutrophil gelatinase\u2013associated lipocalin (u-NGAL) in patients with normal renal function during hip arthroplasty.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In this randomized, double-blinded, placebo-controlled study, 40 patients referred for hip arthroplasty received either 6% HES 130\/0.4 or isotonic saline 0.9%; 7.5 ml\/kg during the first hour of surgery and 5 ml\/kg during the following hours; 38 patients completed the study. U-NGAL, urine albumin, blood pressure, and plasma concentrations of creatinine, renin, NGAL, albumin, angiotensin-II, and aldosterone were measured before, during, and after surgery. U-NGAL was defined as primary outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      There were no significant differences in U-NGAL (mean difference and 95% CI), plasma creatinine, and urine albumin during the study. U-NGAL and urine albumin increased significantly in both groups the morning after surgery but was normalized at follow-up after 10 to 12 days. Mean arterial pressure was significantly higher during the recovery period in the HES group compared with that in the control group (91 [13] and 83 [6] mmHg, mean [SD],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.03). Plasma renin and angiotensin-II were nonsignificantly different in both groups, whereas plasma aldosterone was significantly lower in the HES group. Plasma albumin was reduced in both groups, but to a significantly lower level in the HES group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The study showed no evidence of a harmful effect of intraoperative infusion of 6% HES 130\/0.4 on renal function in patients during hip arthroplasty.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aln.0000000000000413","type":"journal-article","created":{"date-parts":[[2014,8,15]],"date-time":"2014-08-15T08:56:20Z","timestamp":1408092980000},"page":"948-958","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":36,"title":["Lack of Nephrotoxicity by 6% Hydroxyethyl Starch 130\/0.4 during Hip Arthroplasty"],"prefix":"10.1097","volume":"121","author":[{"given":"Anne Sophie Pinholt","family":"Kancir","sequence":"first","affiliation":[{"name":"From the University Clinic in Nephrology and Hypertension, Department of Medical Research and University of Aarhus, Holstebro Hospital, Holstebro, Denmark (A.S.P.K., E.B.P.); Department of Anesthesiology, Holstebro Hospital, Holstebro, Denmark (A.S.P.K., L.P., N.P.E.); and Department of Orthopedics, Holstebro Hospital, Holstebro, Denmark (T.B.H.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Pleckaitiene","sequence":"additional","affiliation":[{"name":"From the University Clinic in Nephrology and Hypertension, Department of Medical Research and University of Aarhus, Holstebro Hospital, Holstebro, Denmark (A.S.P.K., E.B.P.); Department of Anesthesiology, Holstebro Hospital, Holstebro, Denmark (A.S.P.K., L.P., N.P.E.); and Department of Orthopedics, Holstebro Hospital, Holstebro, Denmark (T.B.H.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben B\u00e6k","family":"Hansen","sequence":"additional","affiliation":[{"name":"From the University Clinic in Nephrology and Hypertension, Department of Medical Research and University of Aarhus, Holstebro Hospital, Holstebro, Denmark (A.S.P.K., E.B.P.); Department of Anesthesiology, Holstebro Hospital, Holstebro, Denmark (A.S.P.K., L.P., N.P.E.); and Department of Orthopedics, Holstebro Hospital, Holstebro, Denmark (T.B.H.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels Peter","family":"Ekel\u00f8f","sequence":"additional","affiliation":[{"name":"From the University Clinic in Nephrology and Hypertension, Department of Medical Research and University of Aarhus, Holstebro Hospital, Holstebro, Denmark (A.S.P.K., E.B.P.); Department of Anesthesiology, Holstebro Hospital, Holstebro, Denmark (A.S.P.K., L.P., N.P.E.); and Department of Orthopedics, Holstebro Hospital, Holstebro, Denmark (T.B.H.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erling Bjerregaard","family":"Pedersen","sequence":"additional","affiliation":[{"name":"From the University Clinic in Nephrology and Hypertension, Department of Medical Research and University of Aarhus, Holstebro Hospital, Holstebro, Denmark (A.S.P.K., E.B.P.); Department of Anesthesiology, Holstebro Hospital, Holstebro, Denmark (A.S.P.K., L.P., N.P.E.); and Department of Orthopedics, Holstebro Hospital, Holstebro, Denmark (T.B.H.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20241223","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/bja\/aes377","article-title":"Balanced crystalloid compared with balanced colloid solution using a goal-directed haemodynamic algorithm.","volume":"110","year":"2013","journal-title":"Br J Anaesth"},{"key":"R2-20241223","first-page":"1572","article-title":"Acute intravascular volume expansion with rapidly administered crystalloid or colloid in the setting of moderate hypovolemia.","volume":"96","year":"2003","journal-title":"Anesth Analg"},{"key":"R3-20241223","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1016\/j.annfar.2013.05.006","article-title":"Stroke volume optimization after anaesthetic induction: An open randomized controlled trial comparing 0.9% NaCl versus 6% hydroxyethyl starch 130\/0.4.","volume":"32","year":"2013","journal-title":"Ann Fr Anesth Reanim"},{"key":"R4-20241223","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure\u2014Definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.","volume":"8","year":"2004","journal-title":"Crit Care"},{"key":"R5-20241223","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.ki.5002743","article-title":"The RIFLE criteria and mortality in acute kidney injury: A systematic review.","volume":"73","year":"2008","journal-title":"Kidney Int"},{"key":"R6-20241223","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.bpa.2011.06.004","article-title":"Renal injury in the elderly: Diagnosis, biomarkers and prevention.","volume":"25","year":"2011","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"R7-20241223","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/apha.12054","article-title":"Neutrophil gelatinase-associated lipocalin: Pathophysiology and clinical applications.","volume":"207","year":"2013","journal-title":"Acta Physiol (Oxf)"},{"key":"R8-20241223","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00000542-200609000-00011","article-title":"Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery.","volume":"105","year":"2006","journal-title":"Anesthesiology"},{"key":"R9-20241223","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(05)74811-X","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery.","volume":"365","year":"2005","journal-title":"Lancet"},{"key":"R10-20241223","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/ndt\/gfs127","article-title":"Urinalysis is more specific and urinary neutrophil gelatinase-associated lipocalin is more sensitive for early detection of acute kidney injury.","volume":"28","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R11-20241223","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/11594700-000000000-00000","article-title":"Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: A meta-analysis of clinical studies.","volume":"51","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"R12-20241223","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00000441-200306000-00006","article-title":"Drug-induced renal failure: Update on new medications and unique mechanisms of nephrotoxicity.","volume":"325","year":"2003","journal-title":"Am J Med Sci"},{"key":"R13-20241223","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/S0140-6736(96)07588-5","article-title":"Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients.","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"R14-20241223","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1186\/cc7726","article-title":"Hydroxyethylstarch impairs renal function and induces interstitial proliferation, macrophage infiltration and tubular damage in an isolated renal perfusion model.","volume":"13","year":"2009","journal-title":"Crit Care"},{"key":"R15-20241223","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1053\/j.ajkd.2007.10.044","article-title":"Osmotic nephrosis: Acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes.","volume":"51","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R16-20241223","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0140-6736(93)92345-T","article-title":"Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation.","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"R17-20241223","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1590\/S0102-86502013000100002","article-title":"The effect of 6% hydroxyethyl starch vs. Ringer\u2019s lactate on acute kidney injury after renal ischemia in rats.","volume":"28","year":"2013","journal-title":"Acta Cir Bras"},{"key":"R18-20241223","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00134-009-1704-0","article-title":"The impact of crystalloid and colloid infusion on the kidney in rodent sepsis.","volume":"36","year":"2010","journal-title":"Intensive Care Med"},{"key":"R19-20241223","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/bja\/aen001","article-title":"Comparison of the novel hydroxyethylstarch 130\/0.4 and hydroxyethylstarch 200\/0.6 in brain-dead donor resuscitation on renal function after transplantation.","volume":"100","year":"2008","journal-title":"Br J Anaesth"},{"key":"R20-20241223","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/ALN.0b013e3181a7ec82","article-title":"Hydroxyethyl starches: Different products\u2013different effects.","volume":"111","year":"2009","journal-title":"Anesthesiology"},{"key":"R21-20241223","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1097\/ALN.0000000000000021","article-title":"Equivalent efficacy of hydroxyethyl starch 130\/0.4 and human serum albumin: If nothing is the same, is everything different? The importance of context in clinical trials and statistics.","volume":"119","year":"2013","journal-title":"Anesthesiology"},{"key":"R22-20241223","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1204242","article-title":"Hydroxyethyl starch 130\/0.42 versus Ringer\u2019s acetate in severe sepsis.","volume":"367","year":"2012","journal-title":"N Engl J Med"},{"key":"R23-20241223","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1186\/11358","article-title":"Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130\/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study.","volume":"16","year":"2012","journal-title":"Crit Care"},{"key":"R24-20241223","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa1209759","article-title":"Hydroxyethyl starch or saline for fluid resuscitation in intensive care.","volume":"367","year":"2012","journal-title":"N Engl J Med"},{"key":"R25-20241223","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0034-7094(13)70196-X","article-title":"Volume replacement therapy during hip arthroplasty using hydroxyethyl starch (130\/0.4) compared to lactated Ringer decreases allogeneic blood transfusion and postoperative infection.","volume":"63","year":"2013","journal-title":"Braz J Anesthesiol"},{"key":"R26-20241223","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1399-6576.2005.00714.x","article-title":"Renal effects of hypotensive anaesthesia in combination with acute normovolaemic haemodilution with hydroxyethyl starch 130\/0.4 or isotonic saline.","volume":"49","year":"2005","journal-title":"Acta Anaesthesiol Scand"},{"key":"R27-20241223","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1749-8090-3-45","article-title":"Hydroxyethyl starch versus Ringer solution in cardiopulmonary bypass prime solutions (a randomized controlled trial).","volume":"3","year":"2008","journal-title":"J Cardiothorac Surg"},{"key":"R28-20241223","first-page":"1458","article-title":"Alternatives to albumin administration in hepatocellular carcinoma patients undergoing hepatectomy: An open, randomized clinical trial of efficacy and safety.","volume":"124","year":"2011","journal-title":"Chin Med J (Engl)"},{"key":"R29-20241223","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/ALN.0b013e31827e5569","article-title":"Effect of waxy maize-derived hydroxyethyl starch 130\/0.4 on renal function in surgical patients.","volume":"118","year":"2013","journal-title":"Anesthesiology"},{"key":"R30-20241223","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1213\/ANE.0b013e31827175da","article-title":"Safety of modern starches used during surgery.","volume":"116","year":"2013","journal-title":"Anesth Analg"},{"key":"R31-20241223","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3109\/00365513.2010.486868","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL): Validation of commercially available ELISA.","volume":"70","year":"2010","journal-title":"Scand J Clin Lab Invest"},{"key":"R32-20241223","doi-asserted-by":"crossref","first-page":"F860","DOI":"10.1152\/ajprenal.2001.280.5.F860","article-title":"Effect of water deprivation and hypertonic saline infusion on urinary AQP2 excretion in healthy humans.","volume":"280","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"R33-20241223","doi-asserted-by":"crossref","first-page":"F264","DOI":"10.1152\/ajprenal.00442.2010","article-title":"Effect of high and low sodium intake on urinary aquaporin-2 excretion in healthy humans.","volume":"302","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"R34-20241223","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF00543482","article-title":"Effect of indapamide on renal plasma flow, glomerular filtration rate and arginine vasopressin in plasma in essential hypertension.","volume":"26","year":"1984","journal-title":"Eur J Clin Pharmacol"},{"key":"R35-20241223","first-page":"1064","article-title":"Effect of captopril on renal extraction of renin, angiotensin II, atrial natriuretic peptide and vasopressin, and renal vein renin ratio in patients with arterial hypertension and unilateral renal artery disease.","volume":"8","year":"1993","journal-title":"Nephrol Dial Transplant"},{"key":"R36-20241223","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/jama.2012.13356","article-title":"Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults.","volume":"308","year":"2012","journal-title":"JAMA"},{"key":"R37-20241223","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1097\/ALN.0b013e3182a6b387","article-title":"Six percent hydroxyethyl starch 130\/0.4 (Voluven\u00ae) versus 5% human serum albumin for volume replacement therapy during elective open-heart surgery in pediatric patients.","volume":"119","year":"2013","journal-title":"Anesthesiology"},{"key":"R38-20241223","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijsu.2008.03.002","article-title":"Effect of intraoperative fluid optimisation on renal function in patients undergoing emergency abdominal surgery: A randomised controlled pilot study (ISRCTN 11799696).","volume":"6","year":"2008","journal-title":"Int J Surg"},{"key":"R39-20241223","first-page":"27","article-title":"[Hydroxyethyl starch to protect renal function in laparoscopic surgery].","volume":"56","year":"2009","journal-title":"Rev Esp Anestesiol Reanim"},{"key":"R40-20241223","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1001\/jama.2013.280502","article-title":"Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: The CRISTAL randomized trial.","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"R41-20241223","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2215\/CJN.10921012","article-title":"The risk of AKI in patients treated with intravenous solutions containing hydroxyethyl starch.","volume":"8","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R42-20241223","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/CCM.0b013e3181bc80f1","article-title":"Effect of volume loading with 1 liter intravenous infusions of 0.9% saline, 4% succinylated gelatine (Gelofusine) and 6% hydroxyethyl starch (Voluven) on blood volume and endocrine responses: A randomized, three-way crossover study in healthy volunteers.","volume":"38","year":"2010","journal-title":"Crit Care Med"},{"key":"R43-20241223","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2369-13-15","article-title":"Abnormal increase in urinary aquaporin-2 excretion in response to hypertonic saline in essential hypertension.","volume":"13","year":"2012","journal-title":"BMC Nephrol"}],"container-title":["Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pubs.asahq.org\/anesthesiology\/article-pdf\/121\/5\/948\/484632\/20141100_0-00014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/anesthesiology.pubs.asahq.org\/article.aspx?volume=121&page=948","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:47:48Z","timestamp":1784836068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/ALN.0000000000000413"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/aln.0000000000000413","relation":{},"ISSN":["0003-3022"],"issn-type":[{"value":"0003-3022","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}